At a glance
- Originator Tanabe Seiyaku
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Apr 2003 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 06 Jun 2000 New profile
- 06 Jun 2000 Preclinical development for Cancer in Japan (Unknown route)